Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection
- 31 March 2004
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 56 (3) , 208-214
- https://doi.org/10.1016/j.jhin.2003.12.003
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosisArchives of Disease in Childhood, 2001
- Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosisThorax, 1999
- MRSA in cystic fibrosisJournal of Hospital Infection, 1998
- Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centreJournal of Hospital Infection, 1998
- INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATESTransplantation, 1998
- Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unitJournal of Hospital Infection, 1997
- Methicillin-Resistant Staphylococcus aureus in Hospitals and Long-Term Care Facilities: Microbiology, Epidemiology, and Preventive MeasuresInfection Control & Hospital Epidemiology, 1992
- Penetration into tissues of various drugs active against Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1991
- Prevalence and significance of methicillin‐resistant stapHylococcus aureus in patients with cystic fibrosisPediatric Pulmonology, 1988
- Sputum penetration of fusidic acid in patients with cystic fibrosisEuropean Journal of Pediatrics, 1982